ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work is supported by David Friedberg (C.R.Z. and M.R.W.), NIH grant K08NS096117 (to M.R.W.), the Chan Zuckerberg Biohub (J.L.D. and K.A.Y.), an endowment from the Rachleff family (to M.R.W.), and the Sandler and William K. Bowes, Jr. Foundations (M.R.W., K.C.Z., C.Y.C., S.A.M., and J.L.D.) and the University of California, San Francisco (UCSF) Dean’s Office Medical Student Research Program (G.A.S.).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes